| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |